Another study of 22 patients with advanced CLL demonstrated that a vaccine consisting of irradiated autologous CLL cells admixed with GM-CSF-secreting cells administered after allogeneic hematopoetic transplantation resulted in CD8+ T cells consistently reacting against autologous tumor [17]. The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.